CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
4
Fujian Superpipe
300198
5
WuHan Hvsen Biotechnology
300871
US Stock MarketDetailed Quotes
PFE Pfizer
- 25.550
- -0.590-2.26%
Close Mar 25 16:00 ET
- 25.650
- +0.100+0.39%
Pre 06:09 ET
144.80BMarket Cap18.12P/E (TTM)
26.200High25.510Low47.61MVolume26.160Open26.140Pre Close1.22BTurnover0.84%Turnover Ratio18.12P/E (Static)5.67BShares30.55252wk High1.64P/B144.58BFloat Cap23.71352wk Low1.68Dividend TTM5.66BShs Float53.002Historical High6.58%Div YieldTTM2.64%Amplitude5.306Historical Low25.713Avg Price1Lot Size
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Profile
SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees81000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com
Company Executives
- Name
- Position
- Salary
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 24.65M
- Dr. Chris Boshoff, M.D.,PhD
- Chief Scientific Officer and President, Research and Development
- 7.85M
- Douglas M. Lankler
- Chief Legal Officer and Executive Vice President
- --
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Michael McDermott
- Executive Vice President, Chief Global Supply and Quality Officer
- --
- Lidia L. Fonseca
- Executive Vice President, Chief Digital and Technology Officer
- --
- Aamir Malik
- Chief U.S. Commercial Officer and Executive Vice President
- 8.29M
- Dr. Andrew Baum, M.D.
- Executive Vice President, Chief Strategy and Innovation Officer
- --
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 8.12M
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Suzanne Nora Johnson
- Independent Director
- 410.00K
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 410.00K
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 380.00K
- James Robert Quincey
- Independent Director
- 380.00K
- Joseph J. Echevarria
- Independent Director
- 390.00K
- Cyrus Taraporevala
- Independent Director
- 268.76K
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 390.00K
- Shantanu Narayen
- Lead Independent Director
- 445.00K
- Mortimer J. Buckley
- Independent Director
- 145.60K
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 360.00K
- James C. Smith
- Independent Director
- 390.00K
- Ronald E. Blaylock
- Independent Director
- 360.00K
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 363.00K
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call